The authors investigated the therapeutic potential of targeting anti-apoptotic BCL-2 proteins in glioblastoma.
[Cell Death & Differentiation]
Home Newsletters Neural Cell News Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
